Presentation, medical complications and development of gestational trophoblastic neoplasia of hydatidiform mole after intracytoplasmic sperm injection as compared to hydatidiform mole after spontaneous conception - a retrospective cohort study and literature review. Gynecol Oncol. 2023 Jan 25; 170:179-185.
View in:
PubMed
EMACO for treatment of gestational trophoblastic neoplasia: A multinational multicenter study. Gynecol Oncol. 2023 Jan 20; 170:114-122.
View in:
PubMed
Neutrophil/lymphocyte ratio and other blood cell component counts are not associated with the development of postmolar gestational trophoblastic neoplasia. PLoS One. 2022; 17(12):e0277892.
View in:
PubMed
Current chemotherapeutic options for the treatment of gestational trophoblastic disease. Expert Opin Pharmacother. 2023 Feb; 24(2):245-258.
View in:
PubMed
Influence of COVID-19 pandemic on molar pregnancy and postmolar gestational trophoblastic neoplasia: An observational study. BJOG. 2023 02; 130(3):292-302.
View in:
PubMed
Clinical Presentation, Treatment Outcomes, and Resistance-related Factors in South American Women with Low-risk Postmolar Gestational Trophoblastic Neoplasia. Rev Bras Ginecol Obstet. 2022 Aug; 44(8):746-754.
View in:
PubMed
Correction: ATR and CDK4/6 inhibition target the growth of methotrexate-resistant choriocarcinoma. Oncogene. 2022 Jun; 41(26):3510.
View in:
PubMed
The role of natural killer cells in the immune homeostasis of the maternal fetal interface Orv Hetil. 2022 May 08; 163(19):734-742.
View in:
PubMed
ATR and CDK4/6 inhibition target the growth of methotrexate-resistant choriocarcinoma. Oncogene. 2022 04; 41(18):2540-2554.
View in:
PubMed
Consolidation chemotherapy in postmolar low-risk gestational trophoblastic neoplasia: a systematic review protocol. BMJ Open. 2022 Feb 24; 12(2):e059484.
View in:
PubMed
Clinical characteristics and thyroid function in complete hydatidiform mole complicated by hyperthyroidism. Gynecol Oncol. 2022 04; 165(1):137-142.
View in:
PubMed
Isolation and culture of decidual natural killer cells from term placenta and complete hydatidiform mole. J Reprod Immunol. 2022 03; 150:103475.
View in:
PubMed
Perinatal outcomes of first pregnancy after chemotherapy for gestational trophoblastic neoplasia: a systematic review of observational studies and meta-analysis. Am J Obstet Gynecol. 2022 05; 226(5):633-645.e8.
View in:
PubMed
A novel alternative to cytotoxic chemotherapy for gestational trophoblastic disease. Lancet Oncol. 2021 11; 22(11):1490-1491.
View in:
PubMed
Diagnosis and management of gestational trophoblastic disease: 2021 update. Int J Gynaecol Obstet. 2021 Oct; 155 Suppl 1:86-93.
View in:
PubMed
Gestational trophoblastic neoplasia: one size does not fit all - Authors' reply. Lancet Oncol. 2021 10; 22(10):e421.
View in:
PubMed
Predictive validity of American College of Surgeons: National Surgical Quality Improvement Project risk calculator in patients with ovarian cancer undergoing interval debulking surgery. Int J Gynecol Cancer. 2021 10; 31(10):1356-1362.
View in:
PubMed
Challenges in the Treatment of Low-risk Gestational Trophoblastic Neoplasia. Rev Bras Ginecol Obstet. 2021 Jul; 43(7):503-506.
View in:
PubMed
Impact of clinical characteristics on human chorionic gonadotropin regression after molar pregnancy. Clinics (Sao Paulo). 2021; 76:e2830.
View in:
PubMed
Impact of residual disease at interval debulking surgery on platinum resistance and patterns of recurrence for advanced-stage ovarian cancer. Int J Gynecol Cancer. 2021 10; 31(10):1341-1347.
View in:
PubMed
Folinic acid rescue during methotrexate treatment for low-risk gestational trophoblastic neoplasia - How much is just right? Gynecol Oncol. 2021 09; 162(3):638-644.
View in:
PubMed
Dissection of PIK3CA Aberration for Cervical Adenocarcinoma Outcomes. Cancers (Basel). 2021 Jun 28; 13(13).
View in:
PubMed
Predictors for single-agent resistance in FIGO score 5 or 6 gestational trophoblastic neoplasia: a multicentre, retrospective, cohort study. Lancet Oncol. 2021 08; 22(8):1188-1198.
View in:
PubMed
Loss of Selenoprotein Iodothyronine Deiodinase 3 Expression Correlates with Progression of Complete Hydatidiform Mole to Gestational Trophoblastic Neoplasia. Reprod Sci. 2021 11; 28(11):3200-3211.
View in:
PubMed
Treatment of hydatidiform mole using manual vacuum aspiration: technical and tactical aspects. Int J Gynecol Cancer. 2021 09; 31(9):1299-1300.
View in:
PubMed
Enhanced Efficacy of Aurora Kinase Inhibitors in G2/M Checkpoint Deficient TP53 Mutant Uterine Carcinomas Is Linked to the Summation of LKB1-AKT-p53 Interactions. Cancers (Basel). 2021 May 03; 13(9).
View in:
PubMed
Disease Distribution at Presentation Impacts Benefit of IP Chemotherapy Among Patients with Advanced-Stage Ovarian Cancer. Ann Surg Oncol. 2021 Oct; 28(11):6705-6713.
View in:
PubMed
Triaging abnormal cervical cancer screening tests using p16INK4a detection by ELISA on fresh cervical samples. Am J Reprod Immunol. 2021 07; 86(1):e13394.
View in:
PubMed
Video Hysteroscopy in the Diagnosis of Molar Pregnancy in two Challenging Situations: Complete Mole with Normal hCG and Partial Mole with Early Gestational Age. J Minim Invasive Gynecol. 2021 08; 28(8):1448-1449.
View in:
PubMed
Treatment of high-risk gestational trophoblastic neoplasia and chemoresistance/relapsed disease. Best Pract Res Clin Obstet Gynaecol. 2021 Jul; 74:81-96.
View in:
PubMed
When less is more: regarding the use of chest X-ray instead of computed tomography in screening for pulmonary metastasis in postmolar gestational trophoblastic neoplasia. Br J Cancer. 2021 03; 124(6):1033-1034.
View in:
PubMed
Characterization of miR-200 family members as blood biomarkers for human and laying hen ovarian cancer. Sci Rep. 2020 11 18; 10(1):20071.
View in:
PubMed
Enhanced Efficacy of Simultaneous PD-1 and PD-L1 Immune Checkpoint Blockade in High-Grade Serous Ovarian Cancer. Cancer Res. 2021 01 01; 81(1):158-173.
View in:
PubMed
Distinct microRNA profiles for complete hydatidiform moles at risk of malignant progression. Am J Obstet Gynecol. 2021 04; 224(4):372.e1-372.e30.
View in:
PubMed
Outcomes for relapsed versus resistant low risk gestational trophoblastic neoplasia following single-agent chemotherapy. Gynecol Oncol. 2020 12; 159(3):751-757.
View in:
PubMed
Uterine artery pulsatility index and serum BMP-9 predict resistance to methotrexate therapy in gestational trophoblastic neoplasia: A cohort study. Curr Probl Cancer. 2021 02; 45(1):100622.
View in:
PubMed
Association between antioxidant vitamins and oxidative stress among patients with a complete hydatidiform mole. Clinics (Sao Paulo). 2020; 75:e1724.
View in:
PubMed
Differential blood count as triage tool in evaluation of pelvic masses. Int J Gynecol Cancer. 2021 05; 31(5):733-743.
View in:
PubMed
Use of ablation and ultrasonic aspiration at primary debulking surgery in advanced stage ovarian, fallopian tube, and primary peritoneal cancer. Int J Gynecol Cancer. 2020 07; 30(7):1052-1057.
View in:
PubMed
How to optimize the management of gestational trophoblastic disease during the coronavirus disease era? Am J Obstet Gynecol. 2020 10; 223(4):604-605.
View in:
PubMed
EMA vs EMACO in the treatment of gestational trophoblastic neoplasia. Gynecol Oncol. 2020 07; 158(1):99-104.
View in:
PubMed
Gestational trophoblastic neoplasia lethality among Brazilian women: A retrospective national cohort study. Gynecol Oncol. 2020 08; 158(2):452-459.
View in:
PubMed
Outcomes in the management of high-risk gestational trophoblastic neoplasia in trophoblastic disease centers in South America. Int J Gynecol Cancer. 2020 09; 30(9):1366-1371.
View in:
PubMed
Important insights for non-molar choriocarcinoma. BJOG. 2020 08; 127(9):1108.
View in:
PubMed
MicroRNA-200 family governs ovarian inclusion cyst formation and mode of ovarian cancer spread. Oncogene. 2020 05; 39(20):4045-4060.
View in:
PubMed
Effectiveness and toxicity of second-line actinomycin D in patients with methotrexate-resistant postmolar low-risk gestational trophoblastic neoplasia. Gynecol Oncol. 2020 05; 157(2):372-378.
View in:
PubMed
Comparison of treatment for low-risk GTN with standard 8-day MTX/FA regimen versus modified MTX/FA regimen without chemotherapy on the weekend. Gynecol Oncol. 2020 03; 156(3):598-605.
View in:
PubMed
Considering Changes in the Recommended Human Chorionic Gonadotropin Monitoring After Molar Evacuation. Obstet Gynecol. 2020 01; 135(1):9-11.
View in:
PubMed
State-of-the-Art Workup and Initial Management of Newly Diagnosed Molar Pregnancy and Postmolar Gestational Trophoblastic Neoplasia. J Natl Compr Canc Netw. 2019 11 01; 17(11):1396-1401.
View in:
PubMed
Continued hCG surveillance following chemotherapy for gestational trophoblastic neoplasia: When is enough enough? Gynecol Oncol. 2019 10; 155(1):1-2.
View in:
PubMed
A novel classification of residual disease after interval debulking surgery for advanced-stage ovarian cancer to better distinguish oncologic outcome. Am J Obstet Gynecol. 2019 10; 221(4):326.e1-326.e7.
View in:
PubMed
Assessment of a Chemotherapy Response Score (CRS) System for Tubo-Ovarian High-Grade Serous Carcinoma (HGSC). Int J Gynecol Pathol. 2019 May; 38(3):230-240.
View in:
PubMed
Liquid biopsy of HPV DNA in cervical cancer. J Clin Virol. 2019 05; 114:32-36.
View in:
PubMed
Can carboplatin or etoposide replace actinomycin-d for second-line treatment of methotrexate resistant low-risk gestational trophoblastic neoplasia? Gynecol Oncol. 2019 05; 153(2):277-285.
View in:
PubMed
Clinical characteristics and outcomes after bowel surgery and ostomy formation at the time of debulking surgery for advanced-stage epithelial ovarian carcinoma. Int J Gynecol Cancer. 2019 03; 29(3):585-592.
View in:
PubMed
Infection, thrombosis, and oncologic outcome after interval debulking surgery: Does perioperative blood transfusion matter? Gynecol Oncol. 2019 04; 153(1):63-67.
View in:
PubMed
Targeted Next-Generation Sequencing Reveals Clinically Actionable BRAF and ESR1 Mutations in Low-Grade Serous Ovarian Carcinoma. JCO Precis Oncol. 2018; 2018.
View in:
PubMed
Update on the diagnosis and management of gestational trophoblastic disease. Int J Gynaecol Obstet. 2018 Oct; 143 Suppl 2:79-85.
View in:
PubMed
Evidence for lineage continuity between early serous proliferations (ESPs) in the Fallopian tube and disseminated high-grade serous carcinomas. J Pathol. 2018 11; 246(3):344-351.
View in:
PubMed
Experience With the Use of an Online Community on Facebook for Brazilian Patients With Gestational Trophoblastic Disease: Netnography Study. J Med Internet Res. 2018 09 24; 20(9):e10897.
View in:
PubMed
Prediction of DNA Repair Inhibitor Response in Short-Term Patient-Derived Ovarian Cancer Organoids. Cancer Discov. 2018 11; 8(11):1404-1421.
View in:
PubMed
In Reply. Obstet Gynecol. 2018 07; 132(1):218.
View in:
PubMed
Moving beyond "complete surgical resection" and "optimal": Is low-volume residual disease another option for primary debulking surgery? Gynecol Oncol. 2018 08; 150(2):233-238.
View in:
PubMed
The impact of health insurance status on the stage of cervical cancer diagnosis at a tertiary care center in Massachusetts. Gynecol Oncol. 2018 07; 150(1):67-72.
View in:
PubMed
Gestational Trophoblastic Disease Electronic Consults: What Do Patients and Physicians Want to Know? Int J Gynecol Cancer. 2018 05; 28(4):824-828.
View in:
PubMed
De Novo Tumors of Teratoma: Ganglioneuroma Arising From a Mature Cystic Teratoma of the Ovary. Int J Gynecol Pathol. 2018 May; 37(3):296-300.
View in:
PubMed
Manual Compared With Electric Vacuum Aspiration for Treatment of Molar Pregnancy. Obstet Gynecol. 2018 04; 131(4):652-659.
View in:
PubMed
Meigs to modern times: The evolution of debulking surgery in advanced ovarian cancer. Gynecol Oncol. 2018 06; 149(3):447-454.
View in:
PubMed
Comparison of benign peritoneal fluid- and ovarian cancer ascites-derived extracellular vesicle RNA biomarkers. J Ovarian Res. 2018 Mar 02; 11(1):20.
View in:
PubMed
Extramammary Paget Disease of the Vulva: A Case Series Examining Treatment, Recurrence, and Malignant Transformation. Int J Gynecol Cancer. 2018 03; 28(3):632-638.
View in:
PubMed
Does a human chorionic gonadotropin level of over 20,000?IU/L four weeks after uterine evacuation for complete hydatidiform mole constitute an indication for chemotherapy for gestational trophoblastic neoplasia? Eur J Obstet Gynecol Reprod Biol. 2018 Apr; 223:50-55.
View in:
PubMed
Is chemotherapy always necessary for patients with nonmetastatic gestational trophoblastic neoplasia with histopathological diagnosis of choriocarcinoma? Gynecol Oncol. 2018 02; 148(2):239-246.
View in:
PubMed
Durable remission for a woman with refractory choriocarcinoma treated with anti-endoglin monoclonal antibody and bevacizumab: A case from the New England Trophoblastic Disease Center, Brigham and Women's Hospital and Dana-Farber Cancer Institute. Gynecol Oncol. 2018 01; 148(1):5-11.
View in:
PubMed
Diagnostic potential for a serum miRNA neural network for detection of ovarian cancer. Elife. 2017 10 31; 6.
View in:
PubMed
Effectiveness and toxicity of first-line methotrexate chemotherapy in low-risk postmolar gestational trophoblastic neoplasia: The New England Trophoblastic Disease Center experience. Gynecol Oncol. 2018 01; 148(1):161-167.
View in:
PubMed
Does hormonal contraception during molar pregnancy follow-up influence the risk and clinical aggressiveness of gestational trophoblastic neoplasia after controlling for risk factors? Gynecol Oncol. 2017 11; 147(2):364-370.
View in:
PubMed
Heterotopic Pregnancy Including Intrauterine Normal Gestation and Tubal Complete Hydatidiform Mole: A Case Report and Review of the Literature. Int J Gynecol Pathol. 2017 Sep; 36(5):428-432.
View in:
PubMed
Characterization of MicroRNA-200 pathway in ovarian cancer and serous intraepithelial carcinoma of fallopian tube. BMC Cancer. 2017 Jun 17; 17(1):422.
View in:
PubMed
Liquid biopsy of PIK3CA mutations in cervical cancer in Hong Kong Chinese women. Gynecol Oncol. 2017 08; 146(2):334-339.
View in:
PubMed
Type I interferons modulate methotrexate resistance in gestational trophoblastic neoplasia. Am J Reprod Immunol. 2017 06; 77(6).
View in:
PubMed
Universal Screening for Mismatch-Repair Deficiency in Endometrial Cancers to Identify Patients With Lynch Syndrome and Lynch-like Syndrome. Int J Gynecol Pathol. 2017 Mar; 36(2):115-127.
View in:
PubMed
Correction: Pinin interacts with C-terminal binding proteins for RNA alternative splicing and epithelial cell identity of human ovarian cancer cells. Oncotarget. 2017 02 14; 8(7):12533.
View in:
PubMed
Multiple pregnancies with complete mole and coexisting normal fetus in North and South America: A retrospective multicenter cohort and literature review. Gynecol Oncol. 2017 Apr; 145(1):88-95.
View in:
PubMed
Is chemotherapy necessary for patients with molar pregnancy and human chorionic gonadotropin serum levels raised but falling at 6months after uterine evacuation? Gynecol Oncol. 2016 Dec; 143(3):558-564.
View in:
PubMed
Differentiated exophytic vulvar intraepithelial lesions are genetically distinct from keratinizing squamous cell carcinomas and contain mutations in PIK3CA. Mod Pathol. 2017 03; 30(3):448-458.
View in:
PubMed
Placental site trophoblastic tumors and epithelioid trophoblastic tumors: Biology, natural history, and treatment modalities. Gynecol Oncol. 2017 Jan; 144(1):208-214.
View in:
PubMed
Epithelialization of mouse ovarian tumor cells originating in the fallopian tube stroma. Oncotarget. 2016 Oct 04; 7(40):66077-66086.
View in:
PubMed
Cyclin A1 expression and paclitaxel resistance in human ovarian cancer cells. Eur J Cancer. 2016 11; 67:152-163.
View in:
PubMed
Complete molar pregnancy in adolescents from North and South America: Clinical presentation and risk of gestational trophoblastic neoplasia. Gynecol Oncol. 2016 09; 142(3):496-500.
View in:
PubMed
Effect of race/ethnicity on risk of complete and partial molar pregnancy after adjustment for age. Gynecol Oncol. 2016 10; 143(1):73-76.
View in:
PubMed
Investigating the Impact of Body Mass Index on Intraperitoneal Chemotherapy Outcomes in Ovarian and Fallopian Tube Cancer. Int J Gynecol Cancer. 2016 07; 26(6):1033-40.
View in:
PubMed
Endosalpingiosis: More than just an incidental finding at the time of gynecologic surgery? Gynecol Oncol. 2016 08; 142(2):255-60.
View in:
PubMed
Changing Trends in the Clinical Presentation and Management of Complete Hydatidiform Mole Among Brazilian Women. Int J Gynecol Cancer. 2016 06; 26(5):984-90.
View in:
PubMed
Morphologic correlates of molecular alterations in extrauterine Müllerian carcinomas. Mod Pathol. 2016 08; 29(8):893-903.
View in:
PubMed
Timing of Referral to the New England Trophoblastic Disease Center: Does Referral with Molar Pregnancy Versus Postmolar Gestational Trophoblastic Neoplasia Affect Outcomes? J Reprod Med. 2016 May-Jun; 61(5-6):187-91.
View in:
PubMed
Maternal Near Miss According to World Health Organization Classification Among Women with a Hydatidiform Mole: Experience at the New England Trophoblastic Disease Center, 1994-2013. J Reprod Med. 2016 May-Jun; 61(5-6):210-4.
View in:
PubMed
Centralized Coordination of Decentralized Assistance for Patients with Gestational Trophoblastic Disease in Brazil: A Viable Strategy for Developing Countries. J Reprod Med. 2016 May-Jun; 61(5-6):224-9.
View in:
PubMed
The Role of Surgery in the Management of Gestational Trophoblastic Neoplasia The Hungarian Experience. J Reprod Med. 2016 May-Jun; 61(5-6):197-204.
View in:
PubMed
Gestational Trophoblastic Disease: Presentations from the XVIIIth World Congress on Gestational Trophoblastic Diseases. J Reprod Med. 2016 May-Jun; 61(5-6):185-6.
View in:
PubMed
Effect of race/ethnicity on clinical presentation and risk of gestational trophoblastic neoplasia in patients with complete and partial molar pregnancy at a tertiary care referral center. Am J Obstet Gynecol. 2016 09; 215(3):334.e1-6.
View in:
PubMed
Apoptotic index for prediction of postmolar gestational trophoblastic neoplasia. Am J Obstet Gynecol. 2016 09; 215(3):336.e1-336.e12.
View in:
PubMed
Gestational Trophoblastic Neoplasia Treatment at the Butaro Cancer Center of Excellence in Rwanda. J Glob Oncol. 2016 Dec; 2(6):365-374.
View in:
PubMed
Pinin interacts with C-terminal binding proteins for RNA alternative splicing and epithelial cell identity of human ovarian cancer cells. Oncotarget. 2016 Mar 08; 7(10):11397-411.
View in:
PubMed
Clinical Presentation of Complete Hydatidiform Mole and Partial Hydatidiform Mole at a Regional Trophoblastic Disease Center in the United States Over the Past 2 Decades. Int J Gynecol Cancer. 2016 Feb; 26(2):367-70.
View in:
PubMed
Loss of E-cadherin disrupts ovarian epithelial inclusion cyst formation and collective cell movement in ovarian cancer cells. Oncotarget. 2016 Jan 26; 7(4):4110-21.
View in:
PubMed
The effect of adolescence and advanced maternal age on the incidence of complete and partial molar pregnancy. Gynecol Oncol. 2016 Mar; 140(3):470-3.
View in:
PubMed
Erratum to: Anesthetic Selection and Disease-Free Survival Following Optimal Primary Cytoreductive Surgery for Stage III Epithelial Ovarian Cancer. Ann Surg Oncol. 2015 Dec; 22 Suppl 3:S1606-7.
View in:
PubMed
Erratum to: Anesthetic Selection and Disease-Free Survival Following Optimal Primary Cytoreductive Surgery for Stage III Epithelial Ovarian Cancer. Ann Surg Oncol. 2015 Dec; 22 Suppl 3:S1611.
View in:
PubMed
Optimal management of low-risk gestational trophoblastic neoplasia. Expert Rev Anticancer Ther. 2015; 15(11):1293-304.
View in:
PubMed
Update on the diagnosis and management of gestational trophoblastic disease. Int J Gynaecol Obstet. 2015 Oct; 131 Suppl 2:S123-6.
View in:
PubMed
Molecular changes in endometriosis-associated ovarian clear cell carcinoma. Eur J Cancer. 2015 Sep; 51(13):1831-42.
View in:
PubMed
Changing presentation of complete hydatidiform mole at the New England Trophoblastic Disease Center over the past three decades: does early diagnosis alter risk for gestational trophoblastic neoplasia? Gynecol Oncol. 2015 Jul; 138(1):46-9.
View in:
PubMed
Same-Day Discharge After Laparoscopic Hysterectomy for Endometrial Cancer. Ann Surg Oncol. 2016 Jan; 23(1):178-85.
View in:
PubMed
Response to chemotherapy in overweight/obese patients with low-risk gestational trophoblastic neoplasia. Int J Gynecol Cancer. 2015 May; 25(4):734-40.
View in:
PubMed
Relationship between race and clinical characteristics, extent of disease, and response to chemotherapy in patients with low-risk gestational trophoblastic neoplasia. Gynecol Oncol. 2015 Jul; 138(1):50-4.
View in:
PubMed
Vaginal brachytherapy for early-stage carcinosarcoma of the uterus. Brachytherapy. 2015 Jul-Aug; 14(4):433-9.
View in:
PubMed
Drug-induced death signaling strategy rapidly predicts cancer response to chemotherapy. Cell. 2015 Feb 26; 160(5):977-989.
View in:
PubMed
Genomic aberrations in cervical adenocarcinomas in Hong Kong Chinese women. Int J Cancer. 2015 Aug 15; 137(4):776-83.
View in:
PubMed
Does plastic surgical consultation improve the outcome of patients undergoing radical vulvectomy for squamous cell carcinoma of the vulva? Gynecol Oncol. 2015 Apr; 137(1):60-5.
View in:
PubMed
Diagnosis, classification and treatment of gestational trophoblastic neoplasia. Rev Bras Ginecol Obstet. 2015 Jan; 37(1):42-51.
View in:
PubMed
Anesthetic selection and disease-free survival following optimal primary cytoreductive surgery for stage III epithelial ovarian cancer. Ann Surg Oncol. 2015 Apr; 22(4):1341-8.
View in:
PubMed
Mucinous differentiation does not impact stage or risk of recurrence among patients with grade 1, endometrioid type, endometrial carcinoma. Gynecol Oncol. 2014 Oct; 135(1):54-7.
View in:
PubMed
Women with a partial mole during their first pregnancy and diagnosed earlier in gestation are at increased risk of developing gestational trophoblastic neoplasia. Int J Gynecol Cancer. 2014 Jun; 24(5):941-5.
View in:
PubMed
Gestational trophoblastic disease: presentations from the XVIIth World Congress on Gestational Trophoblastic Diseases. J Reprod Med. 2014 May-Jun; 59(5-6):187.
View in:
PubMed
Subsequent pregnancy outcomes after complete and partial molar pregnancy, recurrent molar pregnancy, and gestational trophoblastic neoplasia: an update from the New England Trophoblastic Disease Center. J Reprod Med. 2014 May-Jun; 59(5-6):188-94.
View in:
PubMed
Changes in the management of high-risk gestational trophoblastic neoplasia in the National Trophoblastic Disease Center of Hungary. J Reprod Med. 2014 May-Jun; 59(5-6):227-34.
View in:
PubMed
What is the optimal treatment for obese patients with advanced ovarian carcinoma? Am J Obstet Gynecol. 2014 Sep; 211(3):231.e1-9.
View in:
PubMed
Protein kinases and associated pathways in pluripotent state and lineage differentiation. Curr Stem Cell Res Ther. 2014; 9(5):366-87.
View in:
PubMed
Endosalpingiosis as it relates to tubal, ovarian and serous neoplastic tissues: an immunohistochemical study of tubal and Müllerian antigens. Gynecol Oncol. 2014 Feb; 132(2):316-21.
View in:
PubMed
Outcome of unexpected adnexal neoplasia discovered during risk reduction salpingo-oophorectomy in women with germ-line BRCA1 or BRCA2 mutations. Gynecol Oncol. 2014 Feb; 132(2):280-6.
View in:
PubMed
Knockdown of core binding factorß alters sphingolipid metabolism. J Cell Physiol. 2013 Dec; 228(12):2350-64.
View in:
PubMed
Gene expression signature of normal cell-of-origin predicts ovarian tumor outcomes. PLoS One. 2013; 8(11):e80314.
View in:
PubMed
Clinical predictors of long-term survival for stage IVB uterine papillary serous carcinoma confined to the abdomen. Gynecol Oncol. 2014 Jan; 132(1):65-9.
View in:
PubMed
A prospective feasibility study of radiation and concurrent bevacizumab for recurrent endometrial cancer. Gynecol Oncol. 2014 Jan; 132(1):55-60.
View in:
PubMed
p-21-Activated kinase-1, -4 and -6 and estrogen receptor expression pattern in normal placenta and gestational trophoblastic diseases. Gynecol Oncol. 2013 Dec; 131(3):759-63.
View in:
PubMed
Overexpression of c-Abl predicts unfavorable outcome in epithelial ovarian cancer. Gynecol Oncol. 2013 Oct; 131(1):69-76.
View in:
PubMed
Changes in clinical presentation of postterm choriocarcinoma at the New England Trophoblastic Disease Center in recent years. Gynecol Oncol. 2013 Sep; 130(3):483-6.
View in:
PubMed
Relationship of margin status and radiation dose to recurrence in post-operative vulvar carcinoma. Gynecol Oncol. 2013 Sep; 130(3):545-9.
View in:
PubMed
BRCA1 expression is epigenetically repressed in sporadic ovarian cancer cells by overexpression of C-terminal binding protein 2. Neoplasia. 2013 Jun; 15(6):600-8.
View in:
PubMed
Reporting of quality measures in gynecologic oncology programs at Prospective Payment System (PPS)-Exempt Cancer Hospitals: an early glimpse into a challenging initiative. Gynecol Oncol. 2013 Sep; 130(3):403-6.
View in:
PubMed
Prognostic factors associated with time to hCG remission in patients with low-risk postmolar gestational trophoblastic neoplasia. Gynecol Oncol. 2013 Aug; 130(2):312-6.
View in:
PubMed
Endometriosis-associated ovarian cancer: a review of pathogenesis. Int J Mol Sci. 2013 Mar 06; 14(3):5367-79.
View in:
PubMed
Does neoadjuvant chemotherapy decrease the risk of hospital readmission following debulking surgery? Gynecol Oncol. 2013 Apr; 129(1):69-73.
View in:
PubMed
Platinum resistance after neoadjuvant chemotherapy compared to primary surgery in patients with advanced epithelial ovarian carcinoma. Gynecol Oncol. 2013 Apr; 129(1):63-8.
View in:
PubMed
Vaginal brachytherapy for early stage uterine papillary serous and clear cell endometrial cancer. Gynecol Oncol. 2013 Apr; 129(1):18-21.
View in:
PubMed
Targeting Notch, a key pathway for ovarian cancer stem cells, sensitizes tumors to platinum therapy. Proc Natl Acad Sci U S A. 2012 Oct 23; 109(43):E2939-48.
View in:
PubMed
Profiles of genomic instability in high-grade serous ovarian cancer predict treatment outcome. Clin Cancer Res. 2012 Oct 15; 18(20):5806-15.
View in:
PubMed
Dysregulated microRNAs in the pathogenesis and progression of cervical neoplasm. Cell Cycle. 2012 Aug 01; 11(15):2876-84.
View in:
PubMed
Characterization of aldehyde dehydrogenase isozymes in ovarian cancer tissues and sphere cultures. BMC Cancer. 2012 Aug 01; 12:329.
View in:
PubMed
Current advances in the management of gestational trophoblastic disease. Gynecol Oncol. 2013 Jan; 128(1):3-5.
View in:
PubMed
Influence of hydatidiform mole follow-up setting on postmolar gestational trophoblastic neoplasia outcomes: a cohort study. J Reprod Med. 2012 Jul-Aug; 57(7-8):305-9.
View in:
PubMed
Clinical epidemiology and management of gestational trophoblastic neoplasia in Hungary in the past 34 years. J Reprod Med. 2012 Jul-Aug; 57(7-8):310-8.
View in:
PubMed
Casein kinase I epsilon interacts with mitochondrial proteins for the growth and survival of human ovarian cancer cells. EMBO Mol Med. 2012 Sep; 4(9):952-63.
View in:
PubMed
Vascular endothelial growth factors and their receptors and regulators in gestational trophoblastic diseases and normal placenta. J Reprod Med. 2012 May-Jun; 57(5-6):197-203.
View in:
PubMed
Gestational trophoblastic neoplasia in adolescents. J Reprod Med. 2012 May-Jun; 57(5-6):237-42.
View in:
PubMed
Complete hydatidiform mole in women aged 40 to 49 years. J Reprod Med. 2012 May-Jun; 57(5-6):254-8.
View in:
PubMed
Molar pregnancy in adolescents. J Reprod Med. 2012 May-Jun; 57(5-6):225-30.
View in:
PubMed
Gestational trophoblastic disease: Presentations from the XVIth World Congress on Gestational Trophoblastic Diseases. J Reprod Med. 2012 May-Jun; 57(5-6):187-8.
View in:
PubMed
A cost analysis of first-line chemotherapy for low-risk gestational trophoblastic neoplasia. J Reprod Med. 2012 May-Jun; 57(5-6):211-8.
View in:
PubMed
Prognostic determinants in patients with uterine and ovarian clear carcinoma. Gynecol Oncol. 2012 May; 125(2):376-80.
View in:
PubMed
Changes in serum CA-125 can predict optimal cytoreduction to no gross residual disease in patients with advanced stage ovarian cancer treated with neoadjuvant chemotherapy. Gynecol Oncol. 2012 May; 125(2):362-6.
View in:
PubMed
Gynecologic cancer. Hematol Oncol Clin North Am. 2012 Feb; 26(1):xi-xii.
View in:
PubMed
Direct identification of an HPV-16 tumor antigen from cervical cancer biopsy specimens. Front Immunol. 2011; 2:75.
View in:
PubMed
Current management of gestational trophoblastic neoplasia. Hematol Oncol Clin North Am. 2012 Feb; 26(1):111-31.
View in:
PubMed
The importance of chemotherapy and radiation in uterine papillary serous carcinoma. Gynecol Oncol. 2011 Dec; 123(3):542-7.
View in:
PubMed
Current chemotherapeutic management of patients with gestational trophoblastic neoplasia. Chemother Res Pract. 2011; 2011:806256.
View in:
PubMed
Matrix metalloproteinases and their inhibitors and inducer in gestational trophoblastic diseases and normal placenta. Gynecol Oncol. 2011 Jul; 122(1):178-82.
View in:
PubMed
Cerebral venous sinus thrombosis presenting as cerebral metastasis in a patient with choriocarcinoma following a non-molar gestation. Gynecol Oncol. 2011 Jul; 122(1):199-200.
View in:
PubMed
Differential hRad17 expression by histologic subtype of ovarian cancer. J Ovarian Res. 2011 Mar 30; 4(1):6.
View in:
PubMed
C terminus of Clostridium perfringens enterotoxin downregulates CLDN4 and sensitizes ovarian cancer cells to Taxol and Carboplatin. Clin Cancer Res. 2011 Mar 01; 17(5):1065-74.
View in:
PubMed
Treating gestational trophoblastic disease. Expert Opin Pharmacother. 2010 Dec; 11(18):3027-39.
View in:
PubMed
Correlates of the preoperative level of CA125 at presentation of ovarian cancer. Gynecol Oncol. 2010 Dec; 119(3):462-8.
View in:
PubMed
Gestational trophoblastic disease. Lancet. 2010 Aug 28; 376(9742):717-29.
View in:
PubMed
Up-regulation of stromal versican expression in advanced stage serous ovarian cancer. Gynecol Oncol. 2010 Oct; 119(1):114-20.
View in:
PubMed
Low-risk gestational trophoblastic neoplasia and methotrexate resistance: predictors of response to treatment with actinomycin D and need for combination chemotherapy. J Reprod Med. 2010 Jul-Aug; 55(7-8):279-84.
View in:
PubMed
Utility of chromosomal chromogenic in situ hybridization as an alternative to flow cytometry and cytogenetics in the diagnosis of early partial hydatidiform moles: a validation study. J Reprod Med. 2010 Jul-Aug; 55(7-8):275-8.
View in:
PubMed
30 years' experience in the treatment of low-risk gestational trophoblastic neoplasia in Hungary. J Reprod Med. 2010 May-Jun; 55(5-6):253-7.
View in:
PubMed
Complete hydatidiform mole in women older than age 50. J Reprod Med. 2010 May-Jun; 55(5-6):208-12.
View in:
PubMed
Gestational trophoblastic disease. Presentations from the XVth World Congress on gestational trophoblastic diseases. J Reprod Med. 2010 May-Jun; 55(5-6):182-3.
View in:
PubMed
The evolving role of hysterectomy in gestational trophoblastic neoplasia at the New England Trophoblastic Disease Center. J Reprod Med. 2010 May-Jun; 55(5-6):194-8.
View in:
PubMed
Age related cellular immune response against complete molar pregnancy. J Reprod Med. 2010 May-Jun; 55(5-6):261-6.
View in:
PubMed
"Hyperglycosylated hCG in the management of quiescent and chemorefractory gestational trophoblastic diseases". Gynecol Oncol. 2010 Jun; 117(3):505-6; author reply 506-7.
View in:
PubMed
The Li-Fraumeni syndrome (LFS): a model for the initiation of p53 signatures in the distal Fallopian tube. J Pathol. 2010 Jan; 220(1):17-23.
View in:
PubMed
Autoantibody profiling to identify biomarkers of key pathogenic pathways in mucinous ovarian cancer. Eur J Cancer. 2010 Jan; 46(1):170-9.
View in:
PubMed
A gene signature predictive for outcome in advanced ovarian cancer identifies a survival factor: microfibril-associated glycoprotein 2. Cancer Cell. 2009 Dec 08; 16(6):521-32.
View in:
PubMed
The epidemiology of ovarian granulosa cell tumors: a case-control study. Gynecol Oncol. 2009 Nov; 115(2):221-5.
View in:
PubMed
Inflammatory cytokine tumor necrosis factor alpha confers precancerous phenotype in an organoid model of normal human ovarian surface epithelial cells. Neoplasia. 2009 Jun; 11(6):529-41.
View in:
PubMed
Clinical practice. Molar pregnancy. N Engl J Med. 2009 Apr 16; 360(16):1639-45.
View in:
PubMed
Management of gestational trophoblastic neoplasia. Semin Oncol. 2009 Apr; 36(2):181-9.
View in:
PubMed
Evaluating methotrexate treatment in patients with low-risk postmolar gestational trophoblastic neoplasia. Gynecol Oncol. 2009 Feb; 112(2):353-7.
View in:
PubMed
Increased HLA-DMB expression in the tumor epithelium is associated with increased CTL infiltration and improved prognosis in advanced-stage serous ovarian cancer. Clin Cancer Res. 2008 Dec 01; 14(23):7667-73.
View in:
PubMed
RUNX3 protein is overexpressed in human epithelial ovarian cancer. Gynecol Oncol. 2009 Feb; 112(2):325-30.
View in:
PubMed
Robotic versus open radical hysterectomy: a comparative study at a single institution. Gynecol Oncol. 2008 Dec; 111(3):425-30.
View in:
PubMed
Current management of gestational trophoblastic diseases. Gynecol Oncol. 2009 Mar; 112(3):654-62.
View in:
PubMed
Vascularization and expression of angiogenic factors in partial and complete molar pregnancies. J Reprod Med. 2008 Aug; 53(8):589-94.
View in:
PubMed
Immune cell profiling in intraplacental and postmolar choriocarcinomas. J Reprod Med. 2008 Aug; 53(8):558-64.
View in:
PubMed
Subsequent pregnancy outcomes in patients with molar pregnancy and persistent gestational trophoblastic neoplasia. J Reprod Med. 2008 Jul; 53(7):481-6.
View in:
PubMed
The changing role of thoracotomy in gestational trophoblastic neoplasia at the New England Trophoblastic Disease Center. J Reprod Med. 2008 Jul; 53(7):493-8.
View in:
PubMed
Antigen-specific T cell immune response detected by skewed T cell receptor usage in normal placenta and complete molar pregnancy. J Reprod Med. 2008 Jul; 53(7):528-34.
View in:
PubMed
Diagnosis and treatment of high-risk metastatic gestational trophoblastic neoplasia in Hungary. J Reprod Med. 2008 Jul; 53(7):541-6.
View in:
PubMed
Gestational trophoblastic disease: presentations from the XLVTH World Congress on Gestational Trophoblastic Diseases. J Reprod Med. 2008 Jul; 53(7):455-6.
View in:
PubMed
Intraplacental choriocarcinoma arising in a second trimester placenta with partial hydatidiform mole. Int J Gynecol Pathol. 2008 Apr; 27(2):247-51.
View in:
PubMed
Pagetoid lesions of the vulva: a collision between malignant melanoma and extramammary Paget disease. Int J Gynecol Pathol. 2008 Apr; 27(2):292-6.
View in:
PubMed
Overexpression of CEACAM6 in borderline and invasive mucinous ovarian neoplasms. Gynecol Oncol. 2008 May; 109(2):234-9.
View in:
PubMed
Classification of ovarian cancer: a genomic analysis. Adv Exp Med Biol. 2008; 622:23-33.
View in:
PubMed
Effect of a c-Met-specific, ATP-competitive small-molecule inhibitor SU11274 on human ovarian carcinoma cell growth, motility, and invasion. Int J Gynecol Cancer. 2008 Sep-Oct; 18(5):976-84.
View in:
PubMed
Overexpression of laminin receptor 1 on decidual cells in partial and complete mole. Gynecol Oncol. 2008 Jan; 108(1):121-5.
View in:
PubMed
Long-term psychosocial adjustment of older vs younger survivors of breast and endometrial cancer. Psychooncology. 2007 Oct; 16(10):895-903.
View in:
PubMed
Immune cell profiling in normal pregnancy, partial and complete molar pregnancy. Gynecol Oncol. 2007 Nov; 107(2):292-7.
View in:
PubMed
Primary fallopian tube malignancies in BRCA-positive women undergoing surgery for ovarian cancer risk reduction. J Clin Oncol. 2007 Sep 01; 25(25):3985-90.
View in:
PubMed
Presence of talc in pelvic lymph nodes of a woman with ovarian cancer and long-term genital exposure to cosmetic talc. Obstet Gynecol. 2007 Aug; 110(2 Pt 2):498-501.
View in:
PubMed
Whole genome oligonucleotide-based array comparative genomic hybridization analysis identified fibroblast growth factor 1 as a prognostic marker for advanced-stage serous ovarian adenocarcinomas. J Clin Oncol. 2007 Jun 01; 25(16):2281-7.
View in:
PubMed
Over-expression of hypoxia-inducible factor 1 alpha in ovarian clear cell carcinoma. Gynecol Oncol. 2007 Aug; 106(2):311-7.
View in:
PubMed
Erratum: Long-term psychosocial adjustment of older vs younger survivors of breast and endometrial cancer. Psychooncology. 2007 May 24; 16(10).
View in:
PubMed
Fertility-sparing surgery for persistent gestational trophoblastic neoplasia in the myometrium: a case report. J Reprod Med. 2007 May; 52(5):431-4.
View in:
PubMed
Claudin-4 overexpression in epithelial ovarian cancer is associated with hypomethylation and is a potential target for modulation of tight junction barrier function using a C-terminal fragment of Clostridium perfringens enterotoxin. Neoplasia. 2007 Apr; 9(4):304-14.
View in:
PubMed
Gestational trophoblastic disease. Clin Obstet Gynecol. 2007 Mar; 50(1):112-22.
View in:
PubMed
Intraepithelial carcinoma of the fimbria and pelvic serous carcinoma: Evidence for a causal relationship. Am J Surg Pathol. 2007 Feb; 31(2):161-9.
View in:
PubMed
An evaluation of the vitamin D3 content in fish: Is the vitamin D content adequate to satisfy the dietary requirement for vitamin D? J Steroid Biochem Mol Biol. 2007 Mar; 103(3-5):642-4.
View in:
PubMed
Etiology and pathogenesis of epithelial ovarian cancer. Dis Markers. 2007; 23(5-6):367-76.
View in:
PubMed
Clinical characteristics of persistent gestational trophoblastic neoplasia after partial hydatidiform molar pregnancy. J Reprod Med. 2006 Nov; 51(11):902-6.
View in:
PubMed
Postevacuation hCG levels and risk of gestational trophoblastic neoplasia among women with partial molar pregnancies. J Reprod Med. 2006 Nov; 51(11):871-4.
View in:
PubMed
25 years' experience in the treatment of gestational trophoblastic neoplasia in Hungary. J Reprod Med. 2006 Oct; 51(10):841-8.
View in:
PubMed
Differential expression of ABCF2 protein among different histologic types of epithelial ovarian cancer and in clear cell adenocarcinomas of different organs. Hum Pathol. 2007 Jan; 38(1):134-9.
View in:
PubMed
Low risk of relapse after achieving undetectable HCG levels in women with partial molar pregnancy. Obstet Gynecol. 2006 Aug; 108(2):393-6.
View in:
PubMed
Negative laparoscopy is highly predictive of negative second-look laparotomy following chemotherapy for ovarian, tubal, and primary peritoneal carcinoma. Gynecol Oncol. 2006 Nov; 103(2):570-4.
View in:
PubMed
Influence of margin status and radiation on recurrence after radical hysterectomy in Stage IB cervical cancer. Int J Radiat Oncol Biol Phys. 2006 Aug 01; 65(5):1501-7.
View in:
PubMed
Selenium binding protein 1 in ovarian cancer. Int J Cancer. 2006 May 15; 118(10):2433-40.
View in:
PubMed
Gestational trophoblastic diseases: 3. Human chorionic gonadotropin-free beta-subunit, a reliable marker of placental site trophoblastic tumors. Gynecol Oncol. 2006 Aug; 102(2):160-4.
View in:
PubMed
Candidate tumor-suppressor gene DLEC1 is frequently downregulated by promoter hypermethylation and histone hypoacetylation in human epithelial ovarian cancer. Neoplasia. 2006 Apr; 8(4):268-78.
View in:
PubMed
Postevacuation hCG levels and risk of gestational trophoblastic neoplasia in women with complete molar pregnancy. Obstet Gynecol. 2006 Mar; 107(3):743.
View in:
PubMed
Expression profiling of mucinous tumors of the ovary identifies genes of clinicopathologic importance. Clin Cancer Res. 2006 Feb 01; 12(3 Pt 1):690-700.
View in:
PubMed
Proteomic-based discovery and characterization of glycosylated eosinophil-derived neurotoxin and COOH-terminal osteopontin fragments for ovarian cancer in urine. Clin Cancer Res. 2006 Jan 15; 12(2):432-41.
View in:
PubMed
Comparison of osteopontin expression in endometrioid endometrial cancer and ovarian endometrioid cancer. Med Oncol. 2006; 23(2):205-12.
View in:
PubMed
PTEN expression in clear cell adenocarcinoma of the ovary. Gynecol Oncol. 2006 Apr; 101(1):71-5.
View in:
PubMed
Whole-genome allelotyping identified distinct loss-of-heterozygosity patterns in mucinous ovarian and appendiceal carcinomas. Clin Cancer Res. 2005 Nov 01; 11(21):7651-7.
View in:
PubMed
Identification of overexpression and amplification of ABCF2 in clear cell ovarian adenocarcinomas by cDNA microarray analyses. Clin Cancer Res. 2005 Oct 01; 11(19 Pt 1):6880-8.
View in:
PubMed
The curative effect of a second curettage in persistent trophoblastic disease: a retrospective cohort survey. Gynecol Oncol. 2005 Oct; 99(1):3-5.
View in:
PubMed
Postevacuation hCG levels and risk of gestational trophoblastic neoplasia in women with complete molar pregnancy. Obstet Gynecol. 2005 Sep; 106(3):548-52.
View in:
PubMed
Ovarian cancer is a heterogeneous disease. Cancer Genet Cytogenet. 2005 Sep; 161(2):170-3.
View in:
PubMed
Quality of life in long-term cervical cancer survivors. Gynecol Oncol. 2005 May; 97(2):310-7.
View in:
PubMed
Conditions associated with antibodies against the tumor-associated antigen MUC1 and their relationship to risk for ovarian cancer. Cancer Epidemiol Biomarkers Prev. 2005 May; 14(5):1125-31.
View in:
PubMed
Defining and measuring reproductive concerns of female cancer survivors. J Natl Cancer Inst Monogr. 2005; (34):94-8.
View in:
PubMed
Clinical applications of microarray technology: creatine kinase B is an up-regulated gene in epithelial ovarian cancer and shows promise as a serum marker. Gynecol Oncol. 2005 Jan; 96(1):77-83.
View in:
PubMed
A pilot trial of TAC (paclitaxel, doxorubicin, and carboplatin) chemotherapy with filgastrim (r-metHuG-CSF) support followed by radiotherapy in patients with "high-risk" endometrial cancer. Gynecol Oncol. 2005 Jan; 96(1):198-203.
View in:
PubMed
Identification of DNA copy number changes in microdissected serous ovarian cancer tissue using a cDNA microarray platform. Cancer Genet Cytogenet. 2004 Dec; 155(2):97-107.
View in:
PubMed
The role of repeat uterine evacuation in the management of persistent gestational trophoblastic disease. Gynecol Oncol. 2004 Dec; 95(3):421-2.
View in:
PubMed
Low risk of relapse after achieving undetectable HCG levels in women with complete molar pregnancy. Obstet Gynecol. 2004 Sep; 104(3):551-4.
View in:
PubMed
Characterisation of human kallikrein 6/protease M expression in ovarian cancer. Br J Cancer. 2004 Aug 16; 91(4):725-31.
View in:
PubMed
Immunohistochemistry for the imprinted gene product IPL/PHLDA2 for facilitating the differential diagnosis of complete hydatidiform mole. J Reprod Med. 2004 Aug; 49(8):630-6.
View in:
PubMed
Predictors of quality of life among long-term survivors of gestational trophoblastic disease. J Reprod Med. 2004 Aug; 49(8):589-94.
View in:
PubMed
Phase I trial of escalating doses of topotecan in combination with a fixed dose of pegylated liposomal doxorubicin in women with müllerian malignancies. Gynecol Oncol. 2004 Jun; 93(3):702-7.
View in:
PubMed
Molecular biology of gestational trophoblastic neoplasia: a review. J Reprod Med. 2004 Jun; 49(6):415-22.
View in:
PubMed
Significance of chest computed tomography findings in the evaluation and treatment of persistent gestational trophoblastic neoplasia. J Reprod Med. 2004 Jun; 49(6):411-4.
View in:
PubMed
Osteopontin as an adjunct to CA125 in detecting recurrent ovarian cancer. Clin Cancer Res. 2004 May 15; 10(10):3474-8.
View in:
PubMed
Cyclin E amplification and overexpression in clear cell adenocarcinoma of the ovary. Oncology. 2004; 67(3-4):291-9.
View in:
PubMed
Psychosocial and reproductive outcomes of gestational trophoblastic diseases. Best Pract Res Clin Obstet Gynaecol. 2003 Dec; 17(6):959-68.
View in:
PubMed
A phase II trial of three sequential doublets for the treatment of advanced müllerian malignancies. Gynecol Oncol. 2003 Nov; 91(2):293-8.
View in:
PubMed
Identification of epithelial cell adhesion molecule autoantibody in patients with ovarian cancer. Clin Cancer Res. 2003 Oct 15; 9(13):4782-91.
View in:
PubMed
Phase II study of liposomal doxorubicin and weekly paclitaxel for recurrent Müllerian tumors. Gynecol Oncol. 2003 Sep; 90(3):610-8.
View in:
PubMed
Comparison of once-daily mometasone furoate versus once-daily budesonide in patients with moderate persistent asthma. Int J Clin Pract. 2003 Sep; 57(7):567-72.
View in:
PubMed
Haptoglobin-alpha subunit as potential serum biomarker in ovarian cancer: identification and characterization using proteomic profiling and mass spectrometry. Clin Cancer Res. 2003 Aug 01; 9(8):2904-11.
View in:
PubMed
Human chorionic gonadotropin follow-up in patients with molar pregnancy: a time for reevaluation. Obstet Gynecol. 2003 Apr; 101(4):732-6.
View in:
PubMed
Osteopontin is down-regulated in hydatidiform mole. Gynecol Oncol. 2003 Apr; 89(1):134-9.
View in:
PubMed
Protein profiling of complete mole and normal placenta using ProteinChip analysis on laser capture microdissected cells. Gynecol Oncol. 2003 Mar; 88(3):424-8.
View in:
PubMed
Successful term pregnancy after selective arterial embolization of symptomatic arteriovenous malformation in the setting of gestational trophoblastic tumor. Gynecol Oncol. 2003 Jan; 88(1):69-72.
View in:
PubMed
Relationship of XIST expression and responses of ovarian cancer to chemotherapy. Mol Cancer Ther. 2002 Aug; 1(10):769-76.
View in:
PubMed
Human papillomaviruses. Applications, caveats and prevention. J Reprod Med. 2002 Jul; 47(7):519-28; discussion 528-9.
View in:
PubMed
Polymorphisms of the estrogen-metabolizing genes CYP17 and catechol-O-methyltransferase and risk of epithelial ovarian cancer. Cancer Res. 2002 Jun 01; 62(11):3058-62.
View in:
PubMed
Methotrexate infusion and folinic acid as primary therapy for nonmetastatic and low-risk metastatic gestational trophoblastic tumors. 15 years of experience. J Reprod Med. 2002 May; 47(5):355-62.
View in:
PubMed
Subsequent pregnancy experience in patients with molar pregnancy and gestational trophoblastic tumor. J Reprod Med. 2002 May; 47(5):380-6.
View in:
PubMed
Quality of life after gestational trophoblastic disease. J Reprod Med. 2002 May; 47(5):387-94.
View in:
PubMed
Recent advances in molecular biology of gestational trophoblastic diseases. A review. J Reprod Med. 2002 May; 47(5):369-79.
View in:
PubMed
Advances in the understanding of placental site trophoblastic tumor. J Reprod Med. 2002 May; 47(5):337-41.
View in:
PubMed
Recent advances in the management of gestational trophoblastic disease: a symposium. J Reprod Med. 2002 May; 47(5):335-6.
View in:
PubMed
Do nontriploid partial hydatidiform moles exist? A histologic and flow cytometric reevaluation of nontriploid specimens. J Reprod Med. 2002 May; 47(5):363-8.
View in:
PubMed
Osteopontin as a potential diagnostic biomarker for ovarian cancer. JAMA. 2002 Apr 03; 287(13):1671-9.
View in:
PubMed
Advances in the management of endometrial adenocarcinoma. A review. J Reprod Med. 2002 Mar; 47(3):173-89; discussion 189-90.
View in:
PubMed
Prostasin, a potential serum marker for ovarian cancer: identification through microarray technology. J Natl Cancer Inst. 2001 Oct 03; 93(19):1458-64.
View in:
PubMed
Second primary or recurrence? Comparative patterns of p53 and K-ras mutations suggest that serous borderline ovarian tumors and subsequent serous carcinomas are unrelated tumors. Cancer Res. 2001 Oct 01; 61(19):7264-7.
View in:
PubMed
Placental site trophoblastic tumor: a 17-year experience at the New England Trophoblastic Disease Center. Gynecol Oncol. 2001 Sep; 82(3):415-9.
View in:
PubMed
A Phase I-II study of 96-hour infusional topotecan and paclitaxel for patients with recurrent Müllerian tumors. Cancer. 2001 Sep 01; 92(5):1156-67.
View in:
PubMed
SPARC (secreted protein acidic and rich in cysteine) induces apoptosis in ovarian cancer cells. Am J Pathol. 2001 Aug; 159(2):609-22.
View in:
PubMed
k-ras mutation may be an early event in mucinous ovarian tumorigenesis. Int J Gynecol Pathol. 2001 Jul; 20(3):244-51.
View in:
PubMed
Whole genome amplification and high-throughput allelotyping identified five distinct deletion regions on chromosomes 5 and 6 in microdissected early-stage ovarian tumors. Cancer Res. 2001 May 15; 61(10):4169-74.
View in:
PubMed
The clinical utility of liposomal doxorubicin in recurrent ovarian cancer. Gynecol Oncol. 2001 May; 81(2):206-12.
View in:
PubMed
Management of gestational trophoblastic diseases: subsequent pregnancy experience. Semin Oncol. 2000 Dec; 27(6):678-85.
View in:
PubMed
Recent advances in gestational trophoblastic disease. J Reprod Med. 2000 Sep; 45(9):692-700.
View in:
PubMed
Recent advances in the understanding of reproductive malignancies. A new section. J Reprod Med. 2000 Sep; 45(9):691.
View in:
PubMed
Sonographic appearance of first trimester complete hydatidiform moles. Ultrasound Obstet Gynecol. 2000 Aug; 16(2):188-91.
View in:
PubMed
Occult ovarian tumors in women with BRCA1 or BRCA2 mutations undergoing prophylactic oophorectomy. J Clin Oncol. 2000 Jul; 18(14):2728-32.
View in:
PubMed
Distinct allelic loss patterns in papillary serous carcinoma of the peritoneum. Am J Clin Pathol. 2000 Jul; 114(1):93-9.
View in:
PubMed
Differential expression of matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 protein and mRNA in epithelial ovarian tumors. Gynecol Oncol. 2000 Jun; 77(3):369-76.
View in:
PubMed
Gestational trophoblastic disease. Curr Treat Options Oncol. 2000 Jun; 1(2):169-75.
View in:
PubMed
Near-maximal fractional oxygen extraction by active skeletal muscle in patients with chronic heart failure. J Appl Physiol (1985). 2000 Jun; 88(6):2138-42.
View in:
PubMed
Expression of epidermal growth factor receptor-related family products in gestational trophoblastic diseases and normal placenta and its relationship with development of postmolar tumor. Gynecol Oncol. 2000 Jun; 77(3):389-93.
View in:
PubMed
Phase I trial of carboplatin, paclitaxel, etoposide, and cyclophosphamide with granulocyte colony stimulating factor as first-line therapy for patients with advanced epithelial ovarian cancer. Gynecol Oncol. 2000 May; 77(2):271-7.
View in:
PubMed
Analysis of p73 in human borderline and invasive ovarian tumor. Oncogene. 2000 Apr 06; 19(15):1885-90.
View in:
PubMed
ras gene activation and infrequent mutation in papillary serous carcinoma of the peritoneum. Gynecol Oncol. 2000 Apr; 77(1):105-11.
View in:
PubMed
BRCA1-related papillary serous carcinoma of the peritoneum has a unique molecular pathogenesis. Cancer Res. 2000 Mar 01; 60(5):1361-4.
View in:
PubMed
Genetic alterations of the WT1 gene in papillary serous carcinoma of the peritoneum. Gynecol Oncol. 2000 Mar; 76(3):369-72.
View in:
PubMed
Identification of a novel 9 cM deletion unit on chromosome 6q23-24 in papillary serous carcinoma of the peritoneum. Hum Pathol. 2000 Mar; 31(3):367-73.
View in:
PubMed
CSF/serum beta-hCG ratio in patients with brain metastases of gestational trophoblastic tumor. J Reprod Med. 2000 Feb; 45(2):94-6.
View in:
PubMed
Bcl-2 and p53 protein expression, apoptosis, and p53 mutation in human epithelial ovarian cancers. Am J Pathol. 2000 Feb; 156(2):409-17.
View in:
PubMed
Differential gene expression pattern between normal human trophoblast and choriocarcinoma cell lines: downregulation of heat shock protein-27 in choriocarcinoma in vitro and in vivo. Gynecol Oncol. 1999 Dec; 75(3):391-6.
View in:
PubMed
Matrix metalloproteinases and their inhibitors in gestational trophoblastic diseases and normal placenta. Gynecol Oncol. 1999 Nov; 75(2):248-53.
View in:
PubMed
Repetitive hydatidiform mole with different male partners. Gynecol Oncol. 1999 Nov; 75(2):224-6.
View in:
PubMed
Outcome of pregnancies occurring within 1 year of hydatidiform mole. Obstet Gynecol. 1999 Oct; 94(4):588-90.
View in:
PubMed
Trophoblastic pulmonary embolization after hysterectomy for invasive complete mole. A case report. J Reprod Med. 1999 Oct; 44(10):908-12.
View in:
PubMed
Outcome of pregnancies occurring before completion of human chorionic gonadotropin follow-up in patients with persistent gestational trophoblastic tumor. Gynecol Oncol. 1999 Jun; 73(3):345-7.
View in:
PubMed
Bulky, barrel-shaped cervical carcinoma (stages IB, IIA, IIB): the prognostic factors for pelvic control and treatment outcome. Am J Clin Oncol. 1999 Jun; 22(3):232-6.
View in:
PubMed
Oral contraceptive use and risk of gestational trophoblastic tumors. J Natl Cancer Inst. 1999 Apr 07; 91(7):635-40.
View in:
PubMed
A new human topoisomerase III that interacts with SGS1 protein. Nucleic Acids Res. 1999 Feb 15; 27(4):993-1000.
View in:
PubMed
Differential expression of NF1 type I and type II isoforms in sporadic borderline and invasive epithelial ovarian tumors. Oncogene. 1999 Jan 07; 18(1):257-62.
View in:
PubMed
BRCA1 gene mutations in women with papillary serous carcinoma of the peritoneum. Obstet Gynecol. 1998 Oct; 92(4 Pt 1):596-600.
View in:
PubMed
Predicting risk of complications with gynecologic laparoscopic surgery. Obstet Gynecol. 1998 Sep; 92(3):327-31.
View in:
PubMed
DOC-2/hDab2, a candidate tumor suppressor gene involved in the development of gestational trophoblastic diseases. Oncogene. 1998 Jul 30; 17(4):419-24.
View in:
PubMed
Genetic imbalance on chromosome 17 in papillary serous carcinoma of the peritoneum. Oncogene. 1998 Jul 02; 16(26):3455-9.
View in:
PubMed
Molecular evidence for multifocal papillary serous carcinoma of the peritoneum in patients with germline BRCA1 mutations. J Natl Cancer Inst. 1998 Jun 03; 90(11):841-5.
View in:
PubMed
Evidence for the multifocal origin of bilateral and advanced human serous borderline ovarian tumors. Cancer Res. 1998 Jun 01; 58(11):2328-30.
View in:
PubMed
DOC-2, a candidate tumor suppressor gene in human epithelial ovarian cancer. Oncogene. 1998 May 07; 16(18):2381-7.
View in:
PubMed
p53, p21, Rb and mdm2 oncoproteins. Expression in normal placenta, partial and complete mole, and choriocarcinoma. J Reprod Med. 1998 Feb; 43(2):119-27.
View in:
PubMed
A Phase I trial of ifosfamide and paclitaxel with granulocyte-colony stimulating factor in the treatment of patients with refractory solid tumors. Cancer. 1998 Feb 01; 82(3):561-6.
View in:
PubMed
Recent advances in gestational trophoblastic disease. Curr Opin Obstet Gynecol. 1998 Feb; 10(1):61-4.
View in:
PubMed
c-myc, c-erbB-2, c-fms and bcl-2 oncoproteins. Expression in normal placenta, partial and complete mole, and choriocarcinoma. J Reprod Med. 1998 Feb; 43(2):101-10.
View in:
PubMed
A novel 4 cM minimal deletion unit on chromosome 6q25.1-q25.2 associated with high grade invasive epithelial ovarian carcinomas. Oncogene. 1998 Jan 29; 16(4):555-9.
View in:
PubMed
A one centimorgan deletion unit on chromosome Xq12 is commonly lost in borderline and invasive epithelial ovarian tumors. Oncogene. 1998 Jan 15; 16(2):197-202.
View in:
PubMed
Natural history of postterm choriocarcinoma. J Reprod Med. 1998 Jan; 43(1):75-80.
View in:
PubMed
Revised FIGO staging system for gestational trophoblastic tumors. Recommendations regarding therapy. J Reprod Med. 1998 Jan; 43(1):37-43.
View in:
PubMed
Complete molar pregnancy. Clinical trends at King Fahad Hospital, Riyadh, Kingdom of Saudi Arabia. J Reprod Med. 1998 Jan; 43(1):11-3.
View in:
PubMed
Complete hydatidiform mole. Comparison of clinicopathologic features, current and past. J Reprod Med. 1998 Jan; 43(1):21-7.
View in:
PubMed
Gestational trophoblastic disease. Subsequent pregnancy outcome, including repeat molar pregnancy. J Reprod Med. 1998 Jan; 43(1):81-6.
View in:
PubMed
Reproductive outcome after methotrexate treatment of tubal pregnancies. J Reprod Med. 1998 Jan; 43(1):28-32.
View in:
PubMed
Identification of a 1300 kilobase deletion unit on chromosome 7q31.3 in invasive epithelial ovarian carcinomas. Oncogene. 1997 Jun 19; 14(24):2979-84.
View in:
PubMed
Enhancement of 131I-mediated cytotoxicity by caffeine. Gynecol Oncol. 1997 May; 65(2):253-7.
View in:
PubMed
A novel 4-cM minimally deleted region on chromosome 11p15.1 associated with high grade nonmucinous epithelial ovarian carcinomas. Cancer Res. 1997 Feb 01; 57(3):387-90.
View in:
PubMed
The management of gestational trophoblastic tumors with etoposide, methotrexate, and actinomycin D. Gynecol Oncol. 1997 Jan; 64(1):156-9.
View in:
PubMed
The diagnosis of molar pregnancy by ultrasound: a continuing challenge. Ultrasound Obstet Gynecol. 1997 Jan; 9(1):4-5.
View in:
PubMed
Chorionic tumors. N Engl J Med. 1996 Dec 05; 335(23):1740-8.
View in:
PubMed
d-fenfluramine treatment of binge eating disorder. Am J Psychiatry. 1996 Nov; 153(11):1455-9.
View in:
PubMed
Frequent microsatellite instability in epithelial borderline ovarian tumors. Cancer Res. 1996 Jun 01; 56(11):2501-5.
View in:
PubMed
Loss of heterozygosity of chromosome 17 in human borderline and invasive epithelial ovarian tumors. Oncogene. 1996 May 16; 12(10):2147-53.
View in:
PubMed
SPARC, an extracellular matrix protein with tumor-suppressing activity in human ovarian epithelial cells. Oncogene. 1996 May 02; 12(9):1895-901.
View in:
PubMed
Prevalence and significance of implantation site trophoblastic atypia in hydatidiform moles and spontaneous abortions. Am J Clin Pathol. 1996 Apr; 105(4):411-6.
View in:
PubMed
Frequency of the BRCA1 185delAG mutation among Jewish women with ovarian cancer and matched population controls. Cancer Res. 1996 Mar 15; 56(6):1250-2.
View in:
PubMed
A 400 kb novel deletion unit centromeric to the BRCA1 gene in sporadic epithelial ovarian cancer. Oncogene. 1996 Feb 15; 12(4):735-40.
View in:
PubMed
Gestational trophoblastic disease. Cancer. 1995 Nov 15; 76(10 Suppl):2079-85.
View in:
PubMed
The changing clinical presentation of complete molar pregnancy. Obstet Gynecol. 1995 Nov; 86(5):775-9.
View in:
PubMed
Twin pregnancies with complete hydatidiform mole and coexisting fetus: use of fluorescent in situ hybridization to evaluate placental X- and Y-chromosomal content. Hum Pathol. 1995 Nov; 26(11):1175-80.
View in:
PubMed
Detailed deletion mapping of chromosome 9p and p16 gene alterations in human borderline and invasive epithelial ovarian tumors. Oncogene. 1995 Oct 05; 11(7):1249-54.
View in:
PubMed
Case-control study of risk factors for partial molar pregnancy. Am J Obstet Gynecol. 1995 Sep; 173(3 Pt 1):788-94.
View in:
PubMed
Clinicopathologic variables, operative characteristics, and DNA ploidy in predicting outcome in ovarian epithelial carcinoma. Obstet Gynecol. 1995 Sep; 86(3):379-85.
View in:
PubMed
Overexpression of the protein tyrosine phosphatase, nonreceptor type 6 (PTPN6), in human epithelial ovarian cancer. Gynecol Oncol. 1995 Jun; 57(3):299-303.
View in:
PubMed
Characterization of human ovarian surface epithelial cells immortalized by human papilloma viral oncogenes (HPV-E6E7 ORFs). Exp Cell Res. 1995 Jun; 218(2):499-507.
View in:
PubMed
Detailed deletion mapping of chromosome 6q in borderline epithelial ovarian tumors. Cancer Res. 1995 May 15; 55(10):2169-72.
View in:
PubMed
Prophylactic chemotherapy of complete molar pregnancy. Semin Oncol. 1995 Apr; 22(2):157-60.
View in:
PubMed
Low-risk metastatic gestational trophoblastic tumors. Semin Oncol. 1995 Apr; 22(2):166-71.
View in:
PubMed
Predicting endometrial cancer among older women who present with abnormal vaginal bleeding. Gynecol Oncol. 1995 Mar; 56(3):376-81.
View in:
PubMed
Evidence for a multifocal origin of papillary serous carcinoma of the peritoneum. Cancer Res. 1995 Feb 01; 55(3):490-2.
View in:
PubMed
Fluoxetine in posttraumatic stress disorder. J Clin Psychiatry. 1994 Dec; 55(12):517-22.
View in:
PubMed
p53 gene mutation in human borderline epithelial ovarian tumors. J Natl Cancer Inst. 1994 Oct 19; 86(20):1549-51.
View in:
PubMed
Two-year follow-up of 263 patients with post/perimenopausal vaginal bleeding and negative initial biopsy. Gynecol Oncol. 1994 Oct; 55(1):56-9.
View in:
PubMed
In vitro regulation of stromelysin-1 in human endometrial stromal cells. Ann N Y Acad Sci. 1994 Sep 06; 732:479-81.
View in:
PubMed
Somatization in patients with dissociative disorders. Am J Psychiatry. 1994 Sep; 151(9):1329-34.
View in:
PubMed
Pseudomyxoma peritonei: a review of 23 cases. Obstet Gynecol. 1994 Jul; 84(1):17-21.
View in:
PubMed
Phase I pharmacokinetic study of the hypoxic cell sensitizer etanidazole with carboplatin and cyclophosphamide in the treatment of advanced ovarian cancer. Int J Radiat Oncol Biol Phys. 1994 Jun 15; 29(3):545-8.
View in:
PubMed
Analysis of HPV-positive and -negative vulvar carcinomas for alterations in c-myc, Ha-, Ki-, and N-ras genes. Gynecol Oncol. 1994 Apr; 53(1):78-83.
View in:
PubMed
Brain metastases of gestational trophoblastic tumor. J Reprod Med. 1994 Mar; 39(3):179-84.
View in:
PubMed
Cytokine regulation of trophoblast steroidogenesis. J Clin Endocrinol Metab. 1994 Mar; 78(3):586-91.
View in:
PubMed
Psychological, social and sexual effects of gestational trophoblastic disease on patients and their partners. J Reprod Med. 1994 Mar; 39(3):163-7.
View in:
PubMed
Clinical features of multiple conception with partial or complete molar pregnancy and coexisting fetuses. J Reprod Med. 1994 Mar; 39(3):147-54.
View in:
PubMed
Subsequent pregnancy experience in patients with gestational trophoblastic disease. New England Trophoblastic Disease Center, 1965-1992. J Reprod Med. 1994 Mar; 39(3):228-32.
View in:
PubMed
Pulmonary metastases of gestational trophoblastic tumor. Risk factors for early respiratory failure. J Reprod Med. 1994 Mar; 39(3):175-8.
View in:
PubMed
Effects of cytokines on epidermal growth factor receptor expression by malignant trophoblast cells in vitro. J Reprod Med. 1994 Mar; 39(3):209-16.
View in:
PubMed
Current management of complete and partial molar pregnancy. J Reprod Med. 1994 Mar; 39(3):139-46.
View in:
PubMed
Molecular cloning of differentially expressed genes in human epithelial ovarian cancer. Gynecol Oncol. 1994 Feb; 52(2):247-52.
View in:
PubMed
Natural history of twin pregnancy with complete hydatidiform mole and coexisting fetus. Obstet Gynecol. 1994 Jan; 83(1):35-42.
View in:
PubMed
The effects of cytokines on human chorionic gonadotropin (hCG) production by a trophoblast cell line. J Reprod Immunol. 1993 Dec; 25(3):235-47.
View in:
PubMed
Screening for ovarian cancer: the preliminary experience of a familial ovarian cancer center. Gynecol Oncol. 1993 Oct; 51(1):12-20.
View in:
PubMed
Dissociative disorders in psychiatric inpatients. Am J Psychiatry. 1993 Jul; 150(7):1037-42.
View in:
PubMed
Cost-effectiveness of strategies to evaluate postmenopausal bleeding. Obstet Gynecol. 1993 Jun; 81(6):968-75.
View in:
PubMed
Sex chromosome composition of complete hydatidiform moles: relationship to metastasis. Am J Obstet Gynecol. 1993 May; 168(5):1547-51.
View in:
PubMed
CA125 measurement in epithelial ovarian cancer: a 10-year anniversary of clinical investigation. Gynecol Oncol. 1993 Apr; 49(1):1-2.
View in:
PubMed
Mutation of K-ras protooncogene in human ovarian epithelial tumors of borderline malignancy. Cancer Res. 1993 Apr 01; 53(7):1489-92.
View in:
PubMed
Molecular genetic evidence of a unifocal origin for human serous ovarian carcinomas. Gynecol Oncol. 1993 Jan; 48(1):5-10.
View in:
PubMed
Molar villous fluid suppresses mononuclear cell cytotoxicity. Gynecol Oncol. 1992 Dec; 47(3):311-6.
View in:
PubMed
The role of cytoreductive surgery in the management of stage IV epithelial ovarian carcinoma. Gynecol Oncol. 1992 Sep; 46(3):367-71.
View in:
PubMed
Preoperative serum CA-125 levels in borderline tumors of the ovary. Gynecol Oncol. 1992 Aug; 46(2):226-9.
View in:
PubMed
Interferon-gamma receptors on human gestational choriocarcinoma cell lines: quantitative and functional studies. Am J Obstet Gynecol. 1992 Aug; 167(2):524-30.
View in:
PubMed
Gestational trophoblastic diseases: recent advances in the understanding of cytogenetics, histopathology, and natural history. Curr Opin Obstet Gynecol. 1992 Aug; 4(4):616-20.
View in:
PubMed
The psychological, social, and sexual consequences of gestational trophoblastic disease. Gynecol Oncol. 1992 Jul; 46(1):74-81.
View in:
PubMed
A flow cytometric study of 137 fresh hydropic placentas: correlation between types of hydatidiform moles and nuclear DNA ploidy. Obstet Gynecol. 1992 Mar; 79(3):403-10.
View in:
PubMed
Involvement of p53 gene in the allelic deletion of chromosome 17p in human ovarian tumors. Anticancer Res. 1991 Nov-Dec; 11(6):1975-82.
View in:
PubMed
A clinicopathologic study of 153 cases of complete hydatidiform mole (1980-1990): histologic grade lacks prognostic significance. Obstet Gynecol. 1991 Sep; 78(3 Pt 1):402-9.
View in:
PubMed
Pathologic features of sharp curettings in complete hydatidiform mole. Predictors of persistent gestational trophoblastic disease. J Reprod Med. 1991 Jan; 36(1):17-20.
View in:
PubMed
Gestational trophoblastic disease of the fallopian tube. J Reprod Med. 1991 Jan; 36(1):57-60.
View in:
PubMed
Management of low-risk metastatic gestational trophoblastic tumors. J Reprod Med. 1991 Jan; 36(1):36-9.
View in:
PubMed
Evolving concepts of molar pregnancy. J Reprod Med. 1991 Jan; 36(1):40-4.
View in:
PubMed
Duplex ultrasonography for persistent gestational trophoblastic tumor. J Reprod Med. 1991 Jan; 36(1):14-6.
View in:
PubMed
Flow cytometric analysis of DNA content in partial hydatidiform moles with persistent gestational trophoblastic tumor. Obstet Gynecol. 1991 Jan; 77(1):111-5.
View in:
PubMed
Reproductive experience after complete and partial molar pregnancy and gestational trophoblastic tumors. J Reprod Med. 1991 Jan; 36(1):3-8.
View in:
PubMed
Epithelial ovarian tumors of borderline malignancy. Gynecol Oncol. 1990 Nov; 39(2):195-8.
View in:
PubMed
A trial of family therapy versus a relatives' group for schizophrenia. Two-year follow-up. Br J Psychiatry. 1990 Oct; 157:571-7.
View in:
PubMed
Recent advances in the biology and treatment of gestational trophoblastic diseases and germ cell tumors. Curr Opin Oncol. 1990 Oct; 2(5):901-5.
View in:
PubMed
Localization of leukocytes and cytokines in chorionic villi of normal placentas and complete hydatidiform moles. Gynecol Oncol. 1990 Jun; 37(3):396-400.
View in:
PubMed
Persistent gestational trophoblastic tumor after partial hydatidiform mole. Gynecol Oncol. 1990 Mar; 36(3):358-62.
View in:
PubMed
Multifetal gestation. Clin Obstet Gynecol. 1990 Mar; 33(1):79-87.
View in:
PubMed
Hepatic scintigraphic changes associated with gestational trophoblastic disease. Eur J Nucl Med. 1990; 16(8-10):721-3.
View in:
PubMed
Methotrexate infusion and folinic acid in the primary therapy of nonmetastatic gestational trophoblastic tumors. Gynecol Oncol. 1990 Jan; 36(1):56-9.
View in:
PubMed
Gestational trophoblastic tumors and malignant ovarian germ cell tumors. Curr Opin Oncol. 1989 Oct; 1(1):119-22.
View in:
PubMed
Gestational trophoblastic diseases. Semin Oncol. 1989 Oct; 16(5):410-6.
View in:
PubMed
Human chorionic gonadotropin and free subunits' serum levels in patients with partial and complete hydatidiform moles. Obstet Gynecol. 1989 Aug; 74(2):212-6.
View in:
PubMed
Repetitive complete and partial hydatidiform mole. Obstet Gynecol. 1989 Aug; 74(2):217-9.
View in:
PubMed
Sonographic diagnosis of partial hydatidiform mole. Obstet Gynecol. 1989 Mar; 73(3 Pt 1):414-8.
View in:
PubMed
Vinblastine, cisplatin and bleomycin as salvage therapy for refractory high-risk metastatic gestational trophoblastic disease. J Reprod Med. 1989 Mar; 34(3):189-92.
View in:
PubMed
A trial of family therapy v. a relatives group for schizophrenia. Br J Psychiatry. 1989 Jan; 154:58-66.
View in:
PubMed
Diagnosis and management of the primary hydatidiform mole. Obstet Gynecol Clin North Am. 1988 Sep; 15(3):491-503.
View in:
PubMed
Insulin-like growth factor-I is an essential regulator of the differentiation of 3T3-L1 adipocytes. J Biol Chem. 1988 Jul 05; 263(19):9402-8.
View in:
PubMed
Clinical experience with placental site trophoblastic tumors at the New England Trophoblastic Disease Center. Obstet Gynecol. 1988 Jun; 71(6 Pt 1):854-7.
View in:
PubMed
Analysis of treatment failure in high-risk metastatic gestational trophoblastic disease. Gynecol Oncol. 1988 Feb; 29(2):199-207.
View in:
PubMed
Cross-reactivity of monoclonal antibodies directed against lymphocyte markers with trophoblast cells of normal placenta, hydatidiform mole, and gestational choriocarcinoma. Gynecol Oncol. 1988 Jan; 29(1):94-100.
View in:
PubMed
Differential production of human chorionic gonadotropin and free subunits in gestational trophoblastic disease. Am J Obstet Gynecol. 1988 Jan; 158(1):193-8.
View in:
PubMed
Effects of products of activated leukocytes (lymphokines and monokines) on the growth of malignant trophoblast cells in vitro. Am J Obstet Gynecol. 1988 Jan; 158(1):199-203.
View in:
PubMed
Subsequent pregnancy outcome in patients with molar pregnancy and gestational trophoblastic tumors. J Reprod Med. 1987 Sep; 32(9):680-4.
View in:
PubMed
Management of complete molar pregnancy. J Reprod Med. 1987 Sep; 32(9):634-9.
View in:
PubMed
Metastatic gestational trophoblastic disease: experience at the New England Trophoblastic Disease Center, 1965 to 1985. Obstet Gynecol. 1987 Mar; 69(3 Pt 1):390-5.
View in:
PubMed
Persistence of partial mole. Am J Clin Pathol. 1987 Mar; 87(3):377-80.
View in:
PubMed
Expression of trophoblast-leukocyte common antigens and placental-type alkaline phosphatase in complete molar pregnancy. Am J Obstet Gynecol. 1986 Aug; 155(2):443-6.
View in:
PubMed
Hormonal measurements in patients with theca lutein cysts and gestational trophoblastic disease. J Reprod Med. 1986 Mar; 31(3):179-83.
View in:
PubMed
Immunobiology of complete molar pregnancy and gestational trophoblastic tumor. Cancer Metastasis Rev. 1986; 5(2):109-23.
View in:
PubMed
Ten year's experience with methotrexate and folinic acid as primary therapy for gestational trophoblastic disease. Gynecol Oncol. 1986 Jan; 23(1):111-8.
View in:
PubMed
Natural history of partial molar pregnancy. Obstet Gynecol. 1985 Nov; 66(5):677-81.
View in:
PubMed
Reactivity of anti-human sperm monoclonal antibodies with normal placenta, hydatidiform mole, and gestational choriocarcinoma. Gynecol Oncol. 1985 Nov; 22(3):334-40.
View in:
PubMed
Gamma-interferon enhances expression of Class I MHC antigens in the weakly HLA+ human choriocarcinoma cell line BeWo, but does not induce MHC expression in the HLA- choriocarcinoma cell line Jar. J Immunol. 1985 Oct; 135(4):2498-501.
View in:
PubMed
Risk factors for complete molar pregnancy from a case-control study. Am J Obstet Gynecol. 1985 Aug 15; 152(8):1016-20.
View in:
PubMed
Intraperitoneal immunotherapy of epithelial ovarian carcinoma with Corynebacterium parvum. Am J Obstet Gynecol. 1985 Aug 15; 152(8):1003-10.
View in:
PubMed
A controlled trial of social intervention in the families of schizophrenic patients: two year follow-up. Br J Psychiatry. 1985 Jun; 146:594-600.
View in:
PubMed
Implantation site in complete molar pregnancy: a study of immunologically competent cells with monoclonal antibodies. Am J Obstet Gynecol. 1985 May 01; 152(1):97-9.
View in:
PubMed
The issue of microinvasive squamous cell carcinoma of the vulva: an evaluation of the criteria of diagnosis and methods of therapy. Obstet Gynecol Surv. 1985 Mar; 40(3):136-43.
View in:
PubMed
Sonographically monitored amniocentesis to decrease intraoperative complications. Obstet Gynecol. 1985 Mar; 65(3):426-30.
View in:
PubMed
Localization of stage-specific embryonic antigens in hydatidiform mole, normal placenta, and gestational choriocarcinoma. Gynecol Oncol. 1985 Jan; 20(1):71-7.
View in:
PubMed
Localization of transferrin receptor in the chorionic villi of complete molar pregnancy. Am J Obstet Gynecol. 1985 Jan 01; 151(1):128-9.
View in:
PubMed
Human chorionic gonadotropin and thyroid function in patients with hydatidiform mole. Am J Obstet Gynecol. 1984 Nov 15; 150(6):723-8.
View in:
PubMed
Immunobiology of molar pregnancy and gestational trophoblastic tumors. J Reprod Med. 1984 Nov; 29(11):796-801.
View in:
PubMed
Staging system for gestational trophoblastic tumors. J Reprod Med. 1984 Nov; 29(11):792-5.
View in:
PubMed
Modified triple chemotherapy in the management of high-risk metastatic gestational trophoblastic tumors. Gynecol Oncol. 1984 Oct; 19(2):173-81.
View in:
PubMed
Histocompatibility antigens (HLA-A,B,C) are not detectable in molar villous fluid. Gynecol Oncol. 1984 Sep; 19(1):74-8.
View in:
PubMed
Identification of material with paternal HLA antigen immunoreactivity from purported circulating immune complexes in patients with gestational trophoblastic neoplasia. J Natl Cancer Inst. 1984 May; 72(5):983-90.
View in:
PubMed
Psychosocial relevance and benefit of neuroleptic maintenance: experience in the United Kingdom. J Clin Psychiatry. 1984 May; 45(5 Pt 2):43-9.
View in:
PubMed
Characterization of antigenic components from circulating immune complexes in patients with gestational trophoblastic neoplasia. Cancer. 1984 Mar 15; 53(6):1316-21.
View in:
PubMed
Reproductive performance after molar pregnancy and gestational trophoblastic tumors. Clin Obstet Gynecol. 1984 Mar; 27(1):221-7.
View in:
PubMed
Choriocarcinoma following term gestation. Gynecol Oncol. 1984 Jan; 17(1):52-7.
View in:
PubMed
The role of regional centers for gestational trophoblastic disease. Adv Exp Med Biol. 1984; 176:383-400.
View in:
PubMed
A radioimmunoassay using a monoclonal antibody to monitor the course of epithelial ovarian cancer. N Engl J Med. 1983 Oct 13; 309(15):883-7.
View in:
PubMed
Comparison of a rabbit heteroantiserum and a murine monoclonal antibody raised against a human epithelial ovarian carcinoma cell line. Am J Obstet Gynecol. 1983 Jul 15; 146(6):607-12.
View in:
PubMed
Pelvic ultrasonography and the management of gestational trophoblastic disease. Gynecol Oncol. 1983 Jun; 15(3):403-12.
View in:
PubMed
Distribution of major histocompatibility (HLA) antigens in chorionic villi of molar pregnancy. Am J Obstet Gynecol. 1983 May 15; 146(2):221-2.
View in:
PubMed
Intraperitoneal immunotherapy of human ovarian carcinoma with Corynebacterium parvum. Cancer Res. 1983 Mar; 43(3):1395-401.
View in:
PubMed
Circulating immune complex levels in patients with molar pregnancy. Obstet Gynecol. 1983 Feb; 61(2):165-8.
View in:
PubMed
Immunopathologic study of the implantation site in molar pregnancy. Am J Obstet Gynecol. 1982 Dec 15; 144(8):925-30.
View in:
PubMed
Methotrexate with citrovorum factor rescue as primary therapy for gestational trophoblastic disease. Cancer. 1982 Nov 15; 50(10):2024-7.
View in:
PubMed
45,X complete hydatidiform mole. Gynecol Oncol. 1982 Oct; 14(2):279-83.
View in:
PubMed
A controlled trial of social intervention in the families of schizophrenic patients. Br J Psychiatry. 1982 Aug; 141:121-34.
View in:
PubMed
Circulating immune complex levels in patients with gestational trophoblastic neoplasia. J Natl Cancer Inst. 1982 Jul; 69(1):23-6.
View in:
PubMed
Nonmetastatic and low-risk metastatic gestational trophoblastic neoplasms. Semin Oncol. 1982 Jun; 9(2):191-7.
View in:
PubMed
Gestational trophoblastic neoplasms. Clinical principles of diagnosis and management. Major Probl Obstet Gynecol. 1982; 14:1-301.
View in:
PubMed
Measurement of human chorionic gonadotropin. Major Probl Obstet Gynecol. 1982; 14:64-97.
View in:
PubMed
Cerebrospinal fluid human chorionic gonadotropin levels in normal pregnancy and choriocarcinoma. Surg Gynecol Obstet. 1981 Nov; 153(5):687-9.
View in:
PubMed
Oral contraceptives and postmolar trophoblastic disease. Obstet Gynecol. 1981 Oct; 58(4):474-7.
View in:
PubMed
Estrogen production as a tumor marker in patients with gonadotropin-producing neoplasms. Cancer Res. 1981 Apr; 41(4):1447-50.
View in:
PubMed
Management of molar pregnancy. J Reprod Med. 1981 Apr; 26(4):208-12.
View in:
PubMed
Management of nonmetastatic trophoblastic tumors. J Reprod Med. 1981 Apr; 26(4):219-22.
View in:
PubMed
Horizons in the management of gestational trophoblastic neoplasia: analysis of treatment failure. J Reprod Med. 1981 Apr; 26(4):227-9.
View in:
PubMed
Pathogenesis of gestational trophoblastic neoplasms. Pathobiol Annu. 1981; 11:391-411.
View in:
PubMed
HL-A antigen frequency distribution in patients with gestational choriocarcinoma and their husbands. Placenta Suppl. 1981; 3:263-7.
View in:
PubMed
Oral contraceptives and post-molar trophoblastic tumours. Lancet. 1980 Oct 04; 2(8197):752.
View in:
PubMed
Pretreatment curettage-A predictor of chemotherapy response in gestational trophoblastic neoplasia. Gynecol Oncol. 1980 Aug; 10(1):39-43.
View in:
PubMed
Psychological and social impact of gestational trophoblastic neoplasia. J Reprod Med. 1980 Jul; 25(1):14-6.
View in:
PubMed
Laparoscopy in the management of gestational trophoblastic neoplasms. J Reprod Med. 1980 Jun; 24(6):261-4.
View in:
PubMed
Embolization of pelvic arteries for control of postpartum hemorrhage. Obstet Gynecol. 1980 Jun; 55(6):754-8.
View in:
PubMed
Natural history of recurrent molar pregnancy. Obstet Gynecol. 1980 Apr; 55(4):457-9.
View in:
PubMed
Methotrexate with citrovorum factor rescue: reduced chemotherapy toxicity in the management of gestational trophoblastic neoplasms. Cancer. 1980 Feb; 45(3):423-6.
View in:
PubMed
Methotrexate with citrovorum factor rescue for nonmetastatic gestational trophoblastic neoplasms. Obstet Gynecol. 1979 Dec; 54(6):725-8.
View in:
PubMed
Invasive cervical carcinoma in young women. Gynecol Oncol. 1979 Dec; 8(3):311-6.
View in:
PubMed
Proliferative sequelae after evacuation of partial hydatidiform mole. Lancet. 1979 Oct 13; 2(8146):804-5.
View in:
PubMed
Increased estrogen production in obese men. J Clin Endocrinol Metab. 1979 Apr; 48(4):633-8.
View in:
PubMed
Natural history of partial hydatidiform moles. Lancet. 1979 Mar 31; 1(8118):719.
View in:
PubMed
Ultrasound-directed percutaneous aspiration biopsy of periaortic lymph nodes in recurrence of cervical carcinoma. Am J Obstet Gynecol. 1978 Aug 15; 131(8):906-8.
View in:
PubMed
Central nervous system involvement by ovarian carcinoma: a complication of prolonged survivial with metastatic disease. Cancer. 1978 Feb; 41(2):776-83.
View in:
PubMed
Endometrial stromal sarcoma arising from vaginal endometriosis. Obstet Gynecol. 1978 Jan; 51(1 Suppl):34s-37s.
View in:
PubMed
Corynebacterium parvum as an immunotherapeutic agent in an ovarian cancer model. Am J Obstet Gynecol. 1977 Aug 01; 128(7):782-6.
View in:
PubMed